Clover Health ($CLOV)

• Expected Adjusted EBITDA Profitable as of FY 2024.

• Levered free cash flow positive with almost no debt.

• Over $417M of cash on balance sheet. Parent entity and unregulated subsidiaries have an additional $137M of cash.

• 7.48% insider ownership.

• Over $5 revenue per share for a company with shares trading at $0.80.

• Cash on hand exceeds market cap.

• Extremely low institutional ownership (~25%).

• Clover Assistant helps doctors diagnose early signs of disease such that they can treat patients more effectively and patients avoid getting sicker. Healthier patients means lower need to pay out. Better patient outcomes at a lower overall cost.

• https://www.businessinsider.com/googles-120-million-divide-acquisition-2014-10